Kailera Therapeutics, Inc. Common Stock (KLRA) — Financial Flexibility Index
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-68.31 Million (operating CF $-68.31 Million minus capex $0.00) represents 0% of total liabilities ($1.06 Billion). Check KLRA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kailera Therapeutics, Inc. Common Stock Financial Flexibility Index (2025–2025)
Historical Financial Flexibility Index trend for Kailera Therapeutics, Inc. Common Stock across 1 annual periods. See KLRA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Kailera Therapeutics, Inc. Common Stock (2025–2025)
Year-by-year free cash flow to debt coverage for Kailera Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Kailera Therapeutics, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-118.12 Million | $-120.21 Million | $1.05 Billion | — |